Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 – Preliminary reportChristopher W. Seymour, Alistair Nichol, Yaseen M. Arabi et al.|medRxiv|2021Cited by 137
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trialYaseen M. Arabi, Anthony Gordon, Lennie Derde et al.|Intensive Care Medicine|2021Cited by 100
Continuation of therapeutic dose heparin for critically ill patients with COVID-19Charlotte Bradbury, Edward Litton, Patrick R. Lawler et al.|Intensive Care Medicine|2023Cited by 6